Xilio Therapeutics Inc XLO
NASDAQ · United States · Health Technology
$8.94-0.11 (-1.22%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.33 | -0.59 | +44.1% | $18.69M | +46.9% | -1.9%$9.18→$9.01 |
| Q4 2024 | 2025-03-11 | -2.80 | -3.08 | +9.1% | — | — | — |
| Q4 2023 | 2024-04-01 | -8.96 | -8.49 | -5.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.